Announcement Date: May 9, 2016
Introduces the Cochrane team’s critical comments on the ECDC experts’ draft advice on neuraminidase inhibitor use.
Med Check TIP in English. Cochrane team criticises the ECDC experts’ draft advice on oseltamivir use: in No 4 (April 2016) | PDF
Eficacy and harm of oseltamivir: ECDC’s draft “Expert Opinion” misinterpret Cochrane’s systematic review results “Med Check The Informed Prescriber” in Japanese 2016: 16(65): 6668.
